Velocity Clinical Research is a globally recognized leader in the clinical trial site industry, specializing in fully integrated research sites. Headquartered in Durham, NC, Velocity partners with pharmaceutical and biotechnology companies to conduct clinical trials across the U.S. and Europe. With over 90 research sites and more than one million participants, they have supported the development of new drugs, medical devices, and diagnostics through Phase I-IV clinical trials. Velocity’s approach focuses on ensuring patient-centric care while accelerating drug development through superior patient recruitment and reliable data collection.